Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Aspen Group trading resumes  16:30
03/13/23
03/13
16:30
03/13/23
16:30
ASPU

Aspen Group

/

+

 
ShowHide Related Items >><<
ASPU Aspen Group
/

+

ASPU Aspen Group
/

+

12/12/22 B. Riley
Aspen Group price target lowered to $1.50 from $3 at B. Riley
09/14/22 Lake Street
Aspen Group downgraded to Hold from Buy at Lake Street
05/27/22 Northland
Aspen Group price target lowered to $3 from $4.50 at Northland
ASPU Aspen Group
/

+

ASPU Aspen Group
/

+

Hot Stocks
Aspen Group to voluntarily delist common stock from Nasdaq » 16:03
03/13/23
03/13
16:03
03/13/23
16:03
ASPU

Aspen Group

/

+

Aspen Group announced…

Aspen Group announced that it has given formal notice to the Nasdaq Stock Market of its intention to voluntarily delist its common stock from the Nasdaq Capital Market and to deregister its common stock under Section 12(b) of the Securities Exchange Act of 1934 .The Company currently anticipates that it will file with the Securities and Exchange Commission a Form 25, Notification of Removal of Listing and/or Registration Under Section 12(b) the Exchange Act, relating to the delisting and deregistration on or about March 23, 2023, with the delisting of its common stock taking effect no earlier than ten days thereafter. As a result, the Company expects that the last trading day of its common stock on the Nasdaq Capital Market will be on or about March 31. Further, on or about April 30 , the Company intends to file a Form 15 with the SEC to suspend the Company's reporting obligations under Section 15(d) of the Exchange Act.

ShowHide Related Items >><<
ASPU Aspen Group
/

+

ASPU Aspen Group
/

+

12/12/22 B. Riley
Aspen Group price target lowered to $1.50 from $3 at B. Riley
09/14/22 Lake Street
Aspen Group downgraded to Hold from Buy at Lake Street
05/27/22 Northland
Aspen Group price target lowered to $3 from $4.50 at Northland
ASPU Aspen Group
/

+

ASPU Aspen Group
/

+

Hot Stocks
Aspen Group trading halted, news pending  16:00
03/13/23
03/13
16:00
03/13/23
16:00
ASPU

Aspen Group

/

+

 
ShowHide Related Items >><<
ASPU Aspen Group
/

+

ASPU Aspen Group
/

+

12/12/22 B. Riley
Aspen Group price target lowered to $1.50 from $3 at B. Riley
09/14/22 Lake Street
Aspen Group downgraded to Hold from Buy at Lake Street
05/27/22 Northland
Aspen Group price target lowered to $3 from $4.50 at Northland
ASPU Aspen Group
/

+

ASPU Aspen Group
/

+

Over a quarter ago
On The Fly
Fly Intel: Pre-market Movers » 08:53
12/14/22
12/14
08:53
12/14/22
08:53
DAL

Delta Air Lines

$33.38 /

-1.39 (-4.00%)

, KYMR

Kymera Therapeutics

$25.94 /

-2.065 (-7.38%)

, RNA

Avidity Biosciences

$10.98 /

-0.535 (-4.65%)

, REVG

Rev Group

$13.28 /

+0.14 (+1.07%)

, ASPU

Aspen Group

/

+

, TSLA

Tesla

$160.93 /

-6.82 (-4.07%)

, BBY

Best Buy

$84.16 /

+1.665 (+2.02%)

, CHTR

Charter

$392.88 /

+8.67 (+2.26%)

Check out this morning's…

ShowHide Related Items >><<
TSLA Tesla
$160.93 /

-6.82 (-4.07%)

RNA Avidity Biosciences
$10.98 /

-0.535 (-4.65%)

REVG Rev Group
$13.28 /

+0.14 (+1.07%)

KYMR Kymera Therapeutics
$25.94 /

-2.065 (-7.38%)

DAL Delta Air Lines
$33.38 /

-1.39 (-4.00%)

CHTR Charter
$392.88 /

+8.67 (+2.26%)

BBY Best Buy
$84.16 /

+1.665 (+2.02%)

ASPU Aspen Group
/

+

DAL Delta Air Lines
$33.38 /

-1.39 (-4.00%)

12/05/22 Jefferies
Jefferies sees 450 point headwind to 2023 Delta CASM-ex if pilot pact passes
12/05/22 Morgan Stanley
Delta Air Lines named new 'Top Pick' in airlines at Morgan Stanley
11/29/22 Jefferies
Jefferies sees Delta walking back 2023 and 2024 targets at investor day
10/24/22 Jefferies
Delta Air Lines price target raised to $40 from $35 at Jefferies
KYMR Kymera Therapeutics
$25.94 /

-2.065 (-7.38%)

12/06/22 Credit Suisse
Credit Suisse downgrades Kymera, sees 'too much risk' into data
12/05/22 Credit Suisse
Kymera Therapeutics downgraded to Neutral from Outperform at Credit Suisse
11/08/22 Raymond James
Kymera Therapeutics initiated with a Market Perform at Raymond James
11/07/22 B. Riley
Kymera Therapeutics price target lowered to $35 from $50 at B. Riley
RNA Avidity Biosciences
$10.98 /

-0.535 (-4.65%)

09/27/22 Chardan
Avidity Biosciences price target lowered to $27 from $29 at Chardan
07/20/22 Chardan
Avidity Biosciences initiated with a Buy at Chardan
07/11/22 Raymond James
Avidity Biosciences initiated with a Strong Buy at Raymond James
REVG Rev Group
$13.28 /

+0.14 (+1.07%)

06/28/22 DA Davidson
Rev Group initiated with a Neutral at DA Davidson
06/09/22 BMO Capital
Rev Group price target lowered to $13 from $15 at BMO Capital
06/07/22 Baird
Rev Group price target lowered to $12 from $14 at Baird
04/08/22 Baird
Rev Group downgraded to Neutral from Outperform at Baird
ASPU Aspen Group
/

+

12/12/22 B. Riley
Aspen Group price target lowered to $1.50 from $3 at B. Riley
09/14/22 Lake Street
Aspen Group downgraded to Hold from Buy at Lake Street
05/27/22 Northland
Aspen Group price target lowered to $3 from $4.50 at Northland
03/10/22 B. Riley
Aspen Group price target lowered to $3 from $6 at B. Riley
TSLA Tesla
$160.93 /

-6.82 (-4.07%)

12/14/22 Citi
Citi explains why Tesla shares sold off on Tuesday
12/13/22 Goldman Sachs
Tesla price target lowered to $235 from $305 at Goldman Sachs
12/08/22 Piper Sandler
Piper says Shanghai Gigafactory rumors 'easier to understand' amid weak November
12/07/22 Bernstein
Tesla may need to take additional price cuts in 2023, says Bernstein
BBY Best Buy
$84.16 /

+1.665 (+2.02%)

12/14/22 BofA
Best Buy downgraded to Underperform at BofA on challenging demand environment
12/14/22 BofA
Best Buy downgraded to Underperform from Neutral at BofA
12/12/22 Goldman Sachs
Best Buy upgraded to Neutral from Sell at Goldman Sachs
11/28/22 Goldman Sachs
Goldman finds small crowds, more promotions over Black Friday weekend
CHTR Charter
$392.88 /

+8.67 (+2.26%)

12/14/22 TD Cowen
Charter price target lowered to $649 from $670 at Cowen
12/14/22 RBC Capital
Charter price target lowered to $460 from $480 at RBC Capital
12/14/22 Credit Suisse
Charter price target lowered to $541 from $551 at Credit Suisse
12/12/22 Benchmark
Liberty Broadband price target lowered to $156 from $201 at Benchmark
TSLA Tesla
$160.93 /

-6.82 (-4.07%)

RNA Avidity Biosciences
$10.98 /

-0.535 (-4.65%)

REVG Rev Group
$13.28 /

+0.14 (+1.07%)

KYMR Kymera Therapeutics
$25.94 /

-2.065 (-7.38%)

DAL Delta Air Lines
$33.38 /

-1.39 (-4.00%)

CHTR Charter
$392.88 /

+8.67 (+2.26%)

BBY Best Buy
$84.16 /

+1.665 (+2.02%)

ASPU Aspen Group
/

+

TSLA Tesla
$160.93 /

-6.82 (-4.07%)

DAL Delta Air Lines
$33.38 /

-1.39 (-4.00%)

CHTR Charter
$392.88 /

+8.67 (+2.26%)

BBY Best Buy
$84.16 /

+1.665 (+2.02%)

TSLA Tesla
$160.93 /

-6.82 (-4.07%)

RNA Avidity Biosciences
$10.98 /

-0.535 (-4.65%)

REVG Rev Group
$13.28 /

+0.14 (+1.07%)

KYMR Kymera Therapeutics
$25.94 /

-2.065 (-7.38%)

DAL Delta Air Lines
$33.38 /

-1.39 (-4.00%)

CHTR Charter
$392.88 /

+8.67 (+2.26%)

BBY Best Buy
$84.16 /

+1.665 (+2.02%)

TSLA Tesla
$160.93 /

-6.82 (-4.07%)

DAL Delta Air Lines
$33.38 /

-1.39 (-4.00%)

CHTR Charter
$392.88 /

+8.67 (+2.26%)

BBY Best Buy
$84.16 /

+1.665 (+2.02%)

Earnings
Aspen Group reports Q2 EPS (9c), consensus (6c) » 16:05
12/13/22
12/13
16:05
12/13/22
16:05
ASPU

Aspen Group

/

+

Reports Q2 revenue…

Reports Q2 revenue $17.1M, consensus $15.55M. "The restructuring initiated in the first quarter of fiscal year 2023 reduced cash used in operations in the second quarter by $4.6M, enabling AGI to generate positive operating cash flow of $1M," continued Mr. Mathews. "At the end of Q2, we issued an 8-K stating that AGI and the Arizona State Board for Private Postsecondary Education entered into a revised stipulated agreement that reduces AU's surety bond requirement from $18.3M to $5.5M and requires a teach-out of the core component of the pre-licensure program, among other requirements. As a result, our surety bond provider has recently agreed to return $1.5 million of the $5 million cash previously being held as collateral, providing additional cash for operations." Mr. Mathews concluded, "As previously stated, we engaged Lampert Capital Advisors to assist with securing an accounts receivable financing agreement. After conducting due diligence on our accounts receivable, Lampert has begun outreach to prospective lenders."

ShowHide Related Items >><<
ASPU Aspen Group
/

+

ASPU Aspen Group
/

+

12/12/22 B. Riley
Aspen Group price target lowered to $1.50 from $3 at B. Riley
09/14/22 Lake Street
Aspen Group downgraded to Hold from Buy at Lake Street
05/27/22 Northland
Aspen Group price target lowered to $3 from $4.50 at Northland
03/10/22 B. Riley
Aspen Group price target lowered to $3 from $6 at B. Riley
ASPU Aspen Group
/

+

Recommendations
Aspen Group price target lowered to $1.50 from $3 at B. Riley » 07:49
12/12/22
12/12
07:49
12/12/22
07:49
ASPU

Aspen Group

/

+

B. Riley analyst Raj…

B. Riley analyst Raj Sharma lowered the firm's price target on Aspen Group to $1.50 from $3 and keeps a Buy rating on the shares ahead of the fiscal Q2 results on December 13. Aspen is "likely to forgo any ambitions" of pursuing pre-licensure programs, restructuring to cut its expense structure, and return to its "profitable roots" of online post-licensure and family nurse practitioner education, Sharma tells investors in a research note. The analyst reduced the target to account for the change in business model and the uncertainty surrounding Aspen.

ShowHide Related Items >><<
ASPU Aspen Group
/

+

ASPU Aspen Group
/

+

09/14/22 Lake Street
Aspen Group downgraded to Hold from Buy at Lake Street
05/27/22 Northland
Aspen Group price target lowered to $3 from $4.50 at Northland
03/10/22 B. Riley
Aspen Group price target lowered to $3 from $6 at B. Riley
02/11/22 B. Riley
Aspen Group price target lowered to $6 from $8 at B. Riley
ASPU Aspen Group
/

+

Hot Stocks
Aspen Group to surrender Arizona approval for pre-licensure RN program » 08:33
09/22/22
09/22
08:33
09/22/22
08:33
ASPU

Aspen Group

/

+

In a regulatory filing,…

In a regulatory filing, Aspen Group disclosed that on September 20, Aspen University and the Arizona State Board of Nursing entered into a consent agreement under which Aspen agreed to voluntarily surrender its program approval for its pre-licensure registered nursing program in Phoenix, Arizona. "Aspen sought the agreement after concluding that it was unable to meet the minimum 80% NCLEX first-time pass rates for calendar year 2022, which is a requirement of an earlier consent agreement that Aspen and the Board signed in March 2022. Aspen did so to minimize uncertainty for its students. Aspen had suspended admissions to its Arizona program in January 2022. Under the terms of the Consent Agreement, Aspen will continue its current Arizona nursing program for all current students and provide regular reports to the Board of Nursing about the program. It remains accountable to the Board to ensure that its current students receive expected instruction and learning opportunities. Once all currently enrolled students in the program have either completed the program or ceased enrollment, or within two years, whichever is sooner, Aspen's program approval will be automatically voluntarily surrendered for a minimum period of two years. Having entered into this agreement with the Arizona State Board of Nursing, Aspen will suspend new enrollments and complete instruction of its program for currently enrolled Core nursing students in Florida, Georgia, Tennessee and Texas," the filing stated.

ShowHide Related Items >><<
ASPU Aspen Group
/

+

ASPU Aspen Group
/

+

09/14/22 Lake Street
Aspen Group downgraded to Hold from Buy at Lake Street
05/27/22 Northland
Aspen Group price target lowered to $3 from $4.50 at Northland
03/10/22 B. Riley
Aspen Group price target lowered to $3 from $6 at B. Riley
02/11/22 B. Riley
Aspen Group price target lowered to $6 from $8 at B. Riley
ASPU Aspen Group
/

+

Downgrade
Aspen Group downgraded to Hold from Buy at Lake Street » 06:48
09/14/22
09/14
06:48
09/14/22
06:48
ASPU

Aspen Group

/

+

Lake Street analyst Eric…

Lake Street analyst Eric Martinuzzi downgraded Aspen Group to Hold from Buy with a price target of 80c, down from $2.50, after the company reported quarterly results and reported that it took action in the quarter to cut staff and marketing spend to drive positive cash flow. Given the "drastic cuts in spending," he now expects Aspen to be AEBITDA positive for the remainder of the year, but Martinuzzi has lowered his revenue estimates for FY23 and FY24 given the reduced marketing spend and in anticipation of lower enrollments.

ShowHide Related Items >><<
ASPU Aspen Group
/

+

ASPU Aspen Group
/

+

05/27/22 Northland
Aspen Group price target lowered to $3 from $4.50 at Northland
03/10/22 B. Riley
Aspen Group price target lowered to $3 from $6 at B. Riley
02/11/22 B. Riley
Aspen Group price target lowered to $6 from $8 at B. Riley
02/11/22 Lake Street
Lake Street keeps Buy on Aspen Group, sees more flexible consent agreement
ASPU Aspen Group
/

+

Earnings
Aspen Group reports Q1 EPS (15c), consensus (11c) » 16:04
09/13/22
09/13
16:04
09/13/22
16:04
ASPU

Aspen Group

/

+

Reports Q1 revenue…

Reports Q1 revenue $18.89M, consensus $18.58M. New student enrollments at AU decreased 46% year-over-year and at USU by 34% year-over-year. New student enrollments were primarily impacted by the enrollment stoppage in the Phoenix pre-licensure program, and the reduction in marketing spend by $1M over the prior quarter. "The revenue decline for the fiscal year 2023 first quarter, which is typically our seasonally slowest quarter, reflects the enrollment stoppage at our Pre-Licensure BSN campuses in Arizona and the effect of the $1 million sequential reduction of marketing spend in the prior quarter," said Michael Mathews, chairman and CEO of AGI. "USU's revenue growth of 12%, primarily due to demand for the MSN-FNP program, partially offset the AU decrease."

ShowHide Related Items >><<
ASPU Aspen Group
/

+

ASPU Aspen Group
/

+

05/27/22 Northland
Aspen Group price target lowered to $3 from $4.50 at Northland
03/10/22 B. Riley
Aspen Group price target lowered to $3 from $6 at B. Riley
02/11/22 B. Riley
Aspen Group price target lowered to $6 from $8 at B. Riley
02/11/22 Lake Street
Lake Street keeps Buy on Aspen Group, sees more flexible consent agreement
ASPU Aspen Group
/

+

Earnings
Aspen Group reports Q4 EPS (8c), two-estimates (6c) » 16:06
07/19/22
07/19
16:06
07/19/22
16:06
ASPU

Aspen Group

$1.20 /

+0.045 (+3.91%)

Reports Q4 revenue…

Reports Q4 revenue $19.4M, consensus $19.52M. At April 30 , the Company had unrestricted cash of $6.5M restricted cash of $6.4M. Cash used in operations for the year ended April 30, 2022 was $11.3 million. Approximately $1.0 million of the cash used in operations is attributed to our Adjusted EBITDA loss, and the remaining use of operating cash is primarily attributed to increased working capital to support the growth in our monthly payment plans. Additionally, cash used in investing activities for the fiscal year ended April 30, 2022 was $4.2 million. To fund cash used in operations and investing activities, the Company issued $10.0 million of convertible debt and obtained a $20.0 million revolving credit facility.

ShowHide Related Items >><<
ASPU Aspen Group
$1.20 /

+0.045 (+3.91%)

ASPU Aspen Group
$1.20 /

+0.045 (+3.91%)

05/27/22 Northland
Aspen Group price target lowered to $3 from $4.50 at Northland
03/10/22 B. Riley
Aspen Group price target lowered to $3 from $6 at B. Riley
02/11/22 B. Riley
Aspen Group price target lowered to $6 from $8 at B. Riley
02/11/22 Lake Street
Lake Street keeps Buy on Aspen Group, sees more flexible consent agreement
ASPU Aspen Group
$1.20 /

+0.045 (+3.91%)

ASPU Aspen Group
$1.20 /

+0.045 (+3.91%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.